1. This study evaluated the effects of post-diagnosis low-dose
aspirin on
prostate cancer-specific mortality and found no overall benefit. 2. The study did find a modest benefit in patients taking
aspirin for at least 5 years after diagnosis. Evidence Rating Level: 2 (Good) Study Rundown: Several recent papers have suggested that regular, low-dose aspirin may […]